Related Experiment Videos
Osteoporosis: pathogenesis, diagnosis, prevention and management
Bailliere'S Clinical Endocrinology and Metabolism
|January 1, 1993
Summary
Osteoporosis is a growing health issue, especially in postmenopausal women. Prevention is crucial, as ideal treatments for established osteoporosis are still limited, necessitating further research into risk prediction and interventions.
Area of Science:
- Gerontology and Bone Health
- Endocrinology and Metabolic Diseases
Background:
- Osteoporosis is a significant and escalating global health concern.
- Postmenopausal women represent the primary demographic affected by osteoporosis.
- Menopausal status and advanced age are critical determinants of fracture risk.
Purpose of the Study:
- To review the scope, pathogenesis, diagnosis, prevention, and treatment of osteoporosis in postmenopausal women.
- To highlight the role of hormone replacement therapy and other modifiable risk factors.
- To discuss emerging therapeutic agents and the need for future research.
Main Methods:
- Review of current literature on osteoporosis in postmenopausal women.
- Focus on diagnostic techniques like dual energy X-ray absorptiometry (DXA).
- Analysis of intervention strategies based on bone loss pathogenesis and risk factor management.
Main Results:
- Dual energy X-ray absorptiometry (DXA) significantly aids in diagnosing osteoporosis and osteopenia.
- Estrogen deficiency accelerates bone loss; hormone replacement therapy can increase bone mass.
- Limited data exists on fracture prevention by new therapeutic agents for established osteoporosis.
Conclusions:
- Hormone replacement therapy is pivotal in osteoporosis prevention and treatment, considering other health factors.
- Addressing modifiable lifestyle and medical risk factors is essential.
- Emphasis on osteoporosis prevention is paramount due to limitations in current treatments and the need for further research on fracture prediction and broad interventions.